Researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) have begun bridging research for a vaccine to prevent and treat pollen disease caused by cedar pollen. This is the first pollen disease vaccine developed so far, and consists of fused cryptomeria (cedar) pollen antigens created by genetic engineering.
Pollen disease is a serious and growing problem in Japan, where an estimated 16% of the population is suffering from symptoms of the allergy, many of whom are living in cities. Besides the discomfort experienced by sufferers, the condition causes work absences and other social problems. Some people have even suffered anaphylactic shock from cedar pollen. Until now there has been no treatment, except for allopathy, such as antihistamines to suppress the symptoms of itchy eyes, runny nose and sneezing. The new vaccine offers the hope of a cure, or at least a way to stimulate the immune system to regulate the allergic response caused by pollen disease.
Yasuyuki Ishii and his colleagues at RCAI’s Vaccine Design Research Team synthesized two kinds of principle cryptomeria pollen antigens using genetic engineering techniques. They found from animal trials that the vaccine was effective in both treating the condition and reducing the likelihood of anaphylactic shock, a risk when natural cryptomeria pollen is present.
The bridging study aims to expand research into clinical applications in humans, to determine dose levels and toxicity levels. Human clinical trials are still needed, but a vaccine to stimulate the immune system to fight cedar pollen disease appears to be in sight.
Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences